Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
09/21/2000 | WO2000055350A1 Human cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055335A1 Pseudotyped lentiviral vectors and uses thereof |
09/21/2000 | WO2000055332A2 Human regulators of intracellular phosphorylation |
09/21/2000 | WO2000055326A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000055323A1 Differential expression of organellar gene products |
09/21/2000 | WO2000055320A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055318A2 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
09/21/2000 | WO2000055317A1 Bsmap, a surface protein expressed specifically in the brain |
09/21/2000 | WO2000055310A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
09/21/2000 | WO2000055308A1 A NOVEL COMPLEX OF HUMAN KALLIKREIN 2 (hK2) AND PROTEASE INHIBITOR-6 (PI-6) IN PROSTATE TUMOR TISSUE AND METHODS OF USING THE COMPLEX |
09/21/2000 | WO2000055306A1 Cells, cell populations, and methods of making and using same |
09/21/2000 | WO2000055298A1 Cell activity assay apparatus and methods for making and using same |
09/21/2000 | WO2000055205A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR |
09/21/2000 | WO2000055201A1 49 human secreted proteins |
09/21/2000 | WO2000055200A1 50 human secreted proteins |
09/21/2000 | WO2000055199A1 47 human secreted proteins |
09/21/2000 | WO2000055198A1 50 human secreted proteins |
09/21/2000 | WO2000055194A2 Tuberculosis antigens and methods of use therefor |
09/21/2000 | WO2000055192A2 Hemocyanin and nucleic acid sequence coding for the same |
09/21/2000 | WO2000055180A2 Human lung cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055178A1 INSECT p53 TUMOR SUPPRESSOR GENES AND PROTEINS |
09/21/2000 | WO2000055177A2 49 human secreted proteins |
09/21/2000 | WO2000055176A2 49 human secreted proteins |
09/21/2000 | WO2000055174A1 Human prostate cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055173A1 Human breast and ovarian cancer associated gene sequences and polypeptides |
09/21/2000 | WO2000055171A1 50 human secreted proteins |
09/21/2000 | WO2000055169A1 TCL-1b GENE AND PROTEIN AND RELATED METHODS AND COMPOSITIONS |
09/21/2000 | WO2000055167A1 2-pyridinethiol derivatives and reagents for activity measurement of nag containing the same |
09/21/2000 | WO2000055149A1 Dimeric compounds and as inhibitors of neuraminidase |
09/21/2000 | WO2000055115A1 A method of permanent fluorescent assay |
09/21/2000 | WO2000054882A1 Individually addressable micro-electromagnetic unit array chips |
09/21/2000 | WO2000054814A1 Screening methods for compounds useful in the regulation of cell proliferation |
09/21/2000 | WO2000054806A1 Insulin-like growth factor binding protein-4 protease |
09/21/2000 | WO2000054581A2 Animal models and methods for sepsis |
09/21/2000 | WO2000054580A2 Leukotriene b4 receptor transgenic mammals |
09/21/2000 | WO2000040751A3 Detecting nucleic acids |
09/21/2000 | WO2000039344A3 Assay device comprising mixed probes |
09/21/2000 | WO2000036144A3 Cancer diagnostic method using p40 subunit of eif3 |
09/21/2000 | WO2000029846A9 COMPOSITIONS AND METHODS RELATING TO THE PEROXISOMAL PROLIFERATOR ACTIVATED RECEPTOR-α MEDIATED PATHWAY |
09/21/2000 | WO2000027868A3 Connective tissue growth factor (ctgf) and methods of use |
09/21/2000 | WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
09/21/2000 | WO2000026227A9 Ldl related protein and uses thereof |
09/21/2000 | WO2000024929A3 Linear amplification mediated pcr (lam pcr) |
09/21/2000 | WO2000023624A9 Methods of screening for risk of proliferative disease and methods for the treatment of proliferative disease |
09/21/2000 | WO2000023623A9 POLYMORPHISM IN Fas PROMOTER AND Fas LIGAND PROMOTER |
09/21/2000 | WO2000022115A3 Assays for identifying functional alterations in the p53 tumor suppressor |
09/21/2000 | WO2000020574A3 Fusions of scaffold proteins with random peptide libraries |
09/21/2000 | WO2000019205A9 Inhibition of pak activation of raf-1 |
09/21/2000 | WO2000018783A9 Mammaglobin, a secreted mammary-specific breast cancer protein |
09/21/2000 | WO2000015792A3 Promotion or inhibition of angiogenesis and cardiovascularization |
09/21/2000 | WO1999064378A3 Directed combinatorial compound library and high throughput assays for screening same |
09/21/2000 | DE19919806A1 Carrier for extracting bacteria comprises a porous material |
09/21/2000 | DE19911835A1 Analytisches Verfahren und zugehöriger Reaktionsträger Analytical method and associated reaction carrier |
09/21/2000 | DE19911130A1 Verfahren zur Identifikation chromosomaler Regionen und Gene A method for identifying chromosomal regions and genes |
09/21/2000 | DE19910912A1 New human RET proto-oncogene variants for determining disease disposition and tailoring specific individual therapies, for e.g. multiple endocrine neoplasia syndrome type 2A or for familial medullary thyroid gland carcinoma |
09/21/2000 | DE10007571A1 Novel DNA probes for detecting and sequencing the transplant antigens DRB1, DPB1 and/or DQB1 |
09/21/2000 | CA2376798A1 Novel methods of diagnosing macrophage development related disorders, compositions, and methods of screening for macrophage development modulators |
09/21/2000 | CA2369319A1 Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
09/21/2000 | CA2368190A1 4-(4-hydroxystyryl)pyridine-containing substrates for an analyte dependent enzyme activation system |
09/21/2000 | CA2368109A1 Detection of melanoma |
09/21/2000 | CA2368105A1 Rapid diagnostic method for distinguishing allergies and infections |
09/21/2000 | CA2368068A1 27 human secreted proteins |
09/21/2000 | CA2367906A1 Tcl-1b gene and protein and related methods and compositions |
09/21/2000 | CA2367160A1 Leukotriene b4 receptor transgenic mammals |
09/21/2000 | CA2366866A1 Electropolymerizable film, and method of making and use thereof |
09/21/2000 | CA2366195A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides |
09/21/2000 | CA2366174A1 Human colon cancer associated gene sequences and polypeptides |
09/21/2000 | CA2366130A1 Human cancer associated gene sequences and polypeptides |
09/21/2000 | CA2366054A1 Lentiviral vector system for high quantity screening |
09/21/2000 | CA2365645A1 Improved expression vector for consistent cellular expression of the tet on repressor in multiple cell types |
09/21/2000 | CA2365540A1 A novel complex of human kallikrein 2 (hk2) and protease inhibitor-6 (pi-6) in prostate tumor tissue and methods of using the complex |
09/21/2000 | CA2365451A1 Nucleic acid molecule comprising a nucleic acid sequence coding for a hemocyanin |
09/21/2000 | CA2365398A1 Method of screening candidate compounds for susceptibility to biliary excretion |
09/21/2000 | CA2365300A1 Centrifugally-enhanced method of determining ligand/target affinity |
09/21/2000 | CA2365232A1 Device and method for microbial susceptibility testing |
09/21/2000 | CA2365125A1 Probe/mobility modifier complexes for multiplex nucleic acid detection |
09/21/2000 | CA2365123A1 Mismatch repair detection |
09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
09/21/2000 | CA2364637A1 50 human secreted proteins |
09/21/2000 | CA2364635A1 47 human secreted proteins |
09/21/2000 | CA2364630A1 50 human secreted proteins |
09/21/2000 | CA2364629A1 Human lung cancer associated gene sequences and polypeptides |
09/21/2000 | CA2364590A1 Human prostate cancer associated gene sequences and polypeptides |
09/21/2000 | CA2364549A1 50 human secreted proteins |
09/21/2000 | CA2364017A1 Animal models and methods for sepsis |
09/21/2000 | CA2363496A1 Differential expression of organellar gene products |
09/21/2000 | CA2363022A1 49 human secreted proteins |
09/21/2000 | CA2363019A1 49 human secreted proteins |
09/21/2000 | CA2362771A1 Genetic analysis |
09/21/2000 | CA2361277A1 49 human secreted proteins |
09/20/2000 | EP1037158A2 Methods and apparatus for analyzing gene expression data |
09/20/2000 | EP1037049A2 Analytical method and carrier therefor |
09/20/2000 | EP1037048A2 Quantitative analysis of glucose or cholesterol in whole blood |
09/20/2000 | EP1036847A1 Oligonucleotide primers for efficient reverse transcription of Hepatitis C Virus (HCV) RNA and methods of use thereof |
09/20/2000 | EP1036846A2 Oligonucleotides for detecting bacteria and detection process |
09/20/2000 | EP1036845A2 Downstream genes of tumor suppressor WT1 |
09/20/2000 | EP1036844A1 Examination method, examination reagent and remedy for diseases caused by variation in lkb1 gene |
09/20/2000 | EP1036332A1 Multiple assay method |
09/20/2000 | EP1036327A2 Hla-e binding |
09/20/2000 | EP1036325A2 Method and test kit for evaluating the oxidative modification of substances containing protein by measuring their antioxidative activity |